• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Akkad Holdings Asia and FKS Group Announce Global Partnership

Share:

December 16, 2019

Akkad Holdings Asia, LLC and the FKS Group today announced a global strategic partnership, FKS Akkad Capital, LP. The partnership will combine Akkad Holdings Asia’s expertise, proven entrepreneurial success and its exceptional network with the know-how, resources and the global reach of the FKS Group.

Efficient distribution plays an increasingly critical role in every aspect of global entrepreneurial ventures, including those in the medical device and emerging health care fields. Companies recognize the need to accelerate the development of innovative ways to ensure their competitiveness in the future. FKS Akkad Capital brings together deep skills in business, global strategy, product ideation, technology development, and organizational change management.

“The FKS Akkad Capital partnership is a powerful combination. The FKS Group’s understanding and proven performance in startup companies, including medical device products, its engineering expertise, innovative approach and its capital resources are uniquely complementary to Akkad Holdings Asia’s team,” said Stephen Shaya, M.D. and President and founder of Akkad Holdings Asia. “With our global experience and the synergistic capabilities of FKS, this partnership will allow us to drive far more business opportunities with urgency,” Dr. Shaya added.

“We are partnering with Akkad Holdings Asia to build a successful portfolio of startup companies and investments that provide the very best in solutions. We will concentrate our resources and efforts, including designing and building the next generation of products and platforms,” said Ms. Fei-Kai Syu, CEO of the FKS Group. “Working together closely as a team, we will discover the potential of new opportunities within or beyond the current business landscape and in areas such as health care and medical devices.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

As a sign of its commitment to the partnership, Akkad Holdings Asia will take an ownership stake in the FKS Group in the near future. Dr. Shaya will also become a board member of the FKS Group and a Managing General Partner of FKS Akkad Capital, LP. It is anticipated that the partnership will be fully operational in the first quarter of 2020.

Source: Prnews Wire

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • TDS Acquires PrescribeWellness from Tabula Rasa Healthcare in $140M DealTDS Acquires PrescribeWellness from Tabula Rasa Healthcare in $140M Deal
  • Carta Healthcare Raises $25M for AI-Powered Clinical Data AbstractionCarta Healthcare Raises $25M for AI-Powered Clinical Data Abstraction
  • Amazon Closes $3.9B Acquisition of One MedicalAmazon Closes $3.9B Acquisition of One Medical
  • Thoma Bravo to buy majority of CentrifyThoma Bravo to buy majority of Centrify
  • ERYTECH and PHERECYDES Announce Merger and Name Change to PHAXIAM TherapeuticsERYTECH and PHERECYDES Announce Merger and Name Change to PHAXIAM Therapeutics
  • Sartorius Acquires Cell Culture Specialist Xell AGSartorius Acquires Cell Culture Specialist Xell AG
  • Skye Completes $17M Financing and Acquires Novel Phase 2-Ready CB1-Inhibiting Monoclonal AntibodySkye Completes $17M Financing and Acquires Novel Phase 2-Ready CB1-Inhibiting Monoclonal Antibody
  • Invitae Sells Reproductive Health Assets to Natera for up to $52.5MInvitae Sells Reproductive Health Assets to Natera for up to $52.5M

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications